CYTOKINETICS, INCORPORATED Accumulated Other Comprehensive Income
CYTOKINETICS, INCORPORATED (CYTK) had Accumulated Other Comprehensive Income of -$3.83 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.83M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.61M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $630.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $34.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$3.83M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$1.61M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $630.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $34.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$158.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.54M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $2.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $5.39M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$1.02M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$539.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$10.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$874.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | -$1.46M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$1.65M 10-Q · filed 2023-05-05 |
| 2022-12-31 | -$3.59M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$5.56M 10-Q · filed 2022-11-04 |
| 2022-06-30 | -$4.49M 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$3.59M 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$869.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | -$65.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$22.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $50.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $149.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $958.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.34M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.61M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $679.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $719.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $761.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $606.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $500.00K 10-K · filed 2020-03-04 |
| 2018-09-30 | $447.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $450.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $489.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $343.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $426.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | -$86.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | -$9.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $137.00K 10-K · filed 2018-03-05 |
| 2016-09-30 | $252.00K 10-Q/A · filed 2016-12-15 |
| 2016-06-30 | $229.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $156.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $149.00K 10-K · filed 2017-03-06 |
| 2015-09-30 | $16.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $12.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | -$6.00K 10-Q · filed 2015-05-04 |
| 2014-12-31 | -$4.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | $24.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $12.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $12.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $7.00K 10-K · filed 2015-03-06 |
| 2013-09-30 | $19.00K 10-Q · filed 2013-11-06 |
| 2013-06-30 | -$1.00K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $10.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $18.00K 10-K · filed 2014-03-07 |
| 2012-09-30 | $13.00K 10-Q · filed 2012-11-07 |
| 2012-06-30 | -$1.00K 10-Q · filed 2012-08-06 |
| 2012-03-31 | -$2.00K 10-Q · filed 2012-05-04 |
| 2011-12-31 | $3.00K 10-K · filed 2013-03-15 |
| 2011-09-30 | $8.00K 10-Q · filed 2011-11-04 |
| 2011-06-30 | $15.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | -$4.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |